Health Care & Life Sciences » Healthcare Provision | BioScrip Inc.

BioScrip Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
842,195.00
984,055.00
982,223.00
935,589.00
817,190.00
708,903
Cost of Goods Sold (COGS) incl. D&A
577,052.00
729,544.00
744,051.00
695,532.00
575,673.00
489,466
Gross Income
265,143.00
254,511.00
238,172.00
240,057.00
241,517.00
219,437
SG&A Expense
254,001.00
319,384.00
249,564.00
235,187.00
226,595.00
202,077
EBIT
11,142.00
64,873.00
-
-
14,922.00
17,360
Unusual Expense
34,013.00
28,579.00
276,255.00
5,409.00
29,702.00
11,293
Non Operating Income/Expense
-
189.00
-
3,954.00
581.00
342
Interest Expense
28,197.00
38,728.00
37,313.00
37,572.00
52,072.00
57,433
Pretax Income
51,068.00
131,991.00
324,960.00
34,157.00
67,433.00
51,024
Income Tax
2,538.00
11,391.00
21,532.00
2,015.00
4,130.00
568
Consolidated Net Income
53,606.00
143,382.00
303,428.00
36,172.00
63,303.00
51,592
Net Income
53,606.00
143,382.00
303,428.00
36,172.00
63,303.00
51,592
Net Income After Extraordinaries
37,558.00
139,296.00
307,149.00
29,579.00
62,410.00
51,491
Net Income Available to Common
69,654.00
147,468.00
298,093.00
51,849.00
74,273.00
62,903
EPS (Basic)
1.08
2.15
4.50
0.55
0.60
0.49
Basic Shares Outstanding
64,560.00
68,476.00
68,710.00
93,740.00
123,791.00
127,942
EPS (Diluted)
1.08
2.15
4.50
0.55
0.60
0.49
Diluted Shares Outstanding
64,560.00
68,476.00
68,710.00
93,740.00
123,791.00
127,942
EBITDA
31,368.00
41,930.00
11,351.00
26,895.00
42,647.00
40,961
Preferred Dividends
-
-
9,810.00
9,084.00
10,077.00
11,210

About BioScrip

View Profile
Address
1600 Broadway
Denver Colorado 80202
United States
Employees -
Website http://www.bioscrip.com
Updated 07/08/2019
BioScrip, Inc. engages in the provision of home infusion and home care management solutions. It partners with physicians, hospital systems, skilled nursing facilities, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services. The firm offers post-acute solutions, infusion services, and respiratory care services and home medical equipment.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.